🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Triple-A Barcelona Study

Recruitingn/aAges 18 Years - anyAllFundació Institut de Recerca de l'Hospital de la …
NCT06827652 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Triple-A Barcelona Study (TABS), is a new hospital-based longitudinal study recruiting consecutive individuals with Abdominal Aortic Aneurysm (AAA) in Barcelona. Individuals that have at least one measurement of the abdominal aortic diameter, either by computed tomography scan or by ultrasound, along with anthropometric, clinical information, and blood samples for most follow-up visits are recruited.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * clinical diagnosis of abdominal aortic aneurysm * infrarenal abdominal aortic diameter greater than 30 mm Exclusion Criteria: * Type B dissections that progress to AAA * saccular aneurysms * mycotic aneurysms * visceral aneurysms * thoracic aneurysms.
💊

What it tests

  • Not listed
📍

Where

1 site
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy